Back to Search
Start Over
Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation.
- Source :
-
American journal of physiology. Gastrointestinal and liver physiology [Am J Physiol Gastrointest Liver Physiol] 2015 Jul 15; Vol. 309 (2), pp. G100-11. Date of Electronic Publication: 2015 Jun 04. - Publication Year :
- 2015
-
Abstract
- Nonalcoholic fatty liver disease is associated with chronic oxidative stress. In our study, we explored the antioxidant effect of antidiabetic metformin on chronic [high-fat diet (HFD)-induced] and acute oxidative stress induced by short-term warm partial ischemia-reperfusion (I/R) or on a combination of both in the liver. Wistar rats were fed a standard diet (SD) or HFD for 10 wk, half of them being administered metformin (150 mg·kg body wt(-1)·day(-1)). Metformin treatment prevented acute stress-induced necroinflammatory reaction, reduced alanine aminotransferase and aspartate aminotransferase serum activity, and diminished lipoperoxidation. The effect was more pronounced in the HFD than in the SD group. The metformin-treated groups exhibited less severe mitochondrial damage (markers: cytochrome c release, citrate synthase activity, mtDNA copy number, mitochondrial respiration) and apoptosis (caspase 9 and caspase 3 activation). Metformin-treated HFD-fed rats subjected to I/R exhibited increased antioxidant enzyme activity as well as attenuated mitochondrial respiratory capacity and ATP resynthesis. The exposure to I/R significantly increased NADH- and succinate-related reactive oxygen species (ROS) mitochondrial production in vitro. The effect of I/R was significantly alleviated by previous metformin treatment. Metformin downregulated the I/R-induced expression of proinflammatory (TNF-α, TLR4, IL-1β, Ccr2) and infiltrating monocyte (Ly6c) and macrophage (CD11b) markers. Our data indicate that metformin reduces mitochondrial performance but concomitantly protects the liver from I/R-induced injury. We propose that the beneficial effect of metformin action is based on a combination of three contributory mechanisms: increased antioxidant enzyme activity, lower mitochondrial ROS production, and reduction of postischemic inflammation.<br /> (Copyright © 2015 the American Physiological Society.)
- Subjects :
- Adenosine Triphosphate metabolism
Animals
Anti-Inflammatory Agents pharmacology
Apoptosis drug effects
Cytoprotection
Diet, High-Fat
Disease Models, Animal
Energy Metabolism drug effects
Inflammation Mediators metabolism
Lipid Peroxidation drug effects
Liver metabolism
Liver pathology
Male
Mitochondria, Liver drug effects
Mitochondria, Liver metabolism
Mitochondria, Liver pathology
Non-alcoholic Fatty Liver Disease etiology
Non-alcoholic Fatty Liver Disease metabolism
Non-alcoholic Fatty Liver Disease pathology
Rats, Wistar
Reperfusion Injury etiology
Reperfusion Injury metabolism
Reperfusion Injury pathology
Time Factors
Antioxidants pharmacology
Liver drug effects
Metformin pharmacology
Non-alcoholic Fatty Liver Disease drug therapy
Oxidative Stress drug effects
Reactive Oxygen Species metabolism
Reperfusion Injury prevention & control
Subjects
Details
- Language :
- English
- ISSN :
- 1522-1547
- Volume :
- 309
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- American journal of physiology. Gastrointestinal and liver physiology
- Publication Type :
- Academic Journal
- Accession number :
- 26045616
- Full Text :
- https://doi.org/10.1152/ajpgi.00329.2014